Extension of Croda contract for SkinBiotixâ... | 19-Oct-2023 | 07:00 | RNS |
health authority approval for AxisBiotix in France | 15-Sep-2023 | 09:00 | RNS |
Update on acne programme | 05-Sep-2023 | 07:00 | RNS |
Holding(s) in Company | 31-Jul-2023 | 12:51 | RNS |
Regulatory Approval | 21-Jun-2023 | 07:00 | RNS |
Business progress update | 14-Jun-2023 | 16:46 | RNS |
SkinBiotix and AxisBiotix Update | 10-May-2023 | 07:00 | RNS |
Director/PDMR Shareholding | 14-Apr-2023 | 07:00 | RNS |
Replacement Half-year Report | 28-Mar-2023 | 13:45 | RNS |
Half-year Report | 28-Mar-2023 | 07:00 | RNS |
Price Monitoring Extension | 27-Mar-2023 | 16:35 | RNS |
Director/PDMR Shareholding | 09-Mar-2023 | 17:18 | RNS |
Director/PDMR Shareholding | 09-Mar-2023 | 17:18 | RNS |
AxisBiotix-Ps™ approved for launch in Europe | 07-Mar-2023 | 07:00 | RNS |
Holding(s) in Company | 20-Feb-2023 | 11:17 | RNS |
Currency | UK Pounds |
Share Price | 9.89p |
Change Today | 0.14p |
% Change | 1.38 % |
52 Week High | 29.00p |
52 Week Low | 7.25p |
Volume | 506,635 |
Shares Issued | 202.26m |
Market Cap | £19.99m |
Value |
---|
Price Trend |
---|
Income |
---|
Growth |
---|
No dividends found |
Time | Volume / Share Price |
11:44 | 31,000 @ 9.60p |
11:44 | 31,000 @ 9.50p |
11:38 | 35,000 @ 9.57p |
11:38 | 35,000 @ 9.50p |
09:38 | 100,000 @ 9.52p |
CEO | Stuart Ashman |
CFO | Manprit Singh Randhawa |
You are here: research